作者:Siyun Nian、Xia Gan、Xiangduan Tan、Zhenpeng Yu、Panfeng Wang、Xing Chen、Guoping Wang
DOI:10.1248/cpb.c15-00261
日期:——
Fourteen novel compounds were prepared and their antagonistic activities against liver X receptors (LXR) α/β were tested in vitro. Compound 26 had an IC50 value of 6.4 µM against LXRα and an IC50 value of 5.6 µM against LXRβ. Docking studies and the results of structure–activity relationships support the further development of this chemical series as LXRα/β antagonists.
研究人员制备了 14 种新型化合物,并在体外测试了它们对肝 X 受体(LXR)α/β 的拮抗活性。化合物 26 对 LXRα 的 IC50 值为 6.4 µM,对 LXRβ 的 IC50 值为 5.6 µM。对接研究和结构-活性关系的结果支持进一步开发该化学系列作为 LXRα/β 拮抗剂。